Purdue Pharma Joins the National Pharmaceutical Council

Andrea Hofelich, ahofelich@npcnow.org, (202) 827-2078
Catherine London, catherine.london@pharma.com, 203-588-7530

(Washington, D.C., Aug. 4, 2016) – The National Pharmaceutical Council (NPC) today announced Purdue Pharma L.P. as its newest member, and that Dr. Tracy Mayne, head of Medical Affairs Strategic Research at Purdue Pharma, will serve as his company’s representative on the NPC Board of Directors.

“I am pleased to welcome Purdue Pharma and Dr. Mayne to NPC,” said NPC President Dan Leonard. “Dr. Mayne brings a wealth of expertise in medical affairs and health policy development that will be an invaluable resource in our efforts to further address issues such as the conduct and application of real-world evidence and the shift toward high-value, patient-centered care. We look forward to Dr. Mayne’s participation on our Board.”

The NPC Board of Directors consists of a representative from each member company.

“NPC’s research and activities are helping to drive the discussion around the importance of defining value as patients seek care centered on their needs,” said Dr. Mayne. “Purdue Pharma welcomes the opportunity to work with NPC and other member companies to advance the conversation on ensuring patient access to high-value care and improving the efficiency and effectiveness of our health care delivery systems.”

In becoming an NPC member, Purdue Pharma joins with other leading research-based pharmaceutical companies, including AbbVie, Allergan, Inc., Amgen, Inc., Astellas Pharma US, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals, Biogen, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, Genentech, Inc., Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., Sanofi, Takeda Pharmaceuticals USA, Inc., and Teva Pharmaceuticals.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

About Purdue Pharma L.P.
Purdue Pharma and associated U.S. companies are privately-held pharmaceutical companies known for pioneering research in chronic pain and opioids with abuse-deterrent properties. The Company is engaged in the research, development, production, and distribution of prescription and over-the-counter medicines, as well as hospital products. Purdue Pharma is committed to advancing the care of patients to make a positive impact on healthcare — and on lives. Purdue Pharma’s headquarters are located in Stamford, Conn. For more information please visit www.purduepharma.com or follow the company on Twitter, Instagram and LinkedIn.